Importer of Controlled Substances; Notice of Registration, 31312-31313 [E9-15445]

Download as PDF 31312 Federal Register / Vol. 74, No. 124 / Tuesday, June 30, 2009 / Notices The Commission further determined that the public interest factors enumerated in section 337(d)(1) (19 U.S.C. 1337(d)(1)) do not preclude issuance of the limited exclusion order or the cease and desist order. Finally, the Commission determined that no bond is required to permit temporary importation during the period of Presidential review (19 U.S.C. 1337(j)). The Commission’s orders and opinion were delivered to the President and to the United States Trade Representative on the day of its issuance. The Commission has terminated this investigation. The authority for the Commission’s determination is contained in section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in sections 210.42, 210.45, and 210.50 of the Commission’s Rules of Practice and Procedure (19 CFR 210.42, 210.45, 210.50). By order of the Commission. Issued June 24, 2009. Marilyn R. Abbott, Secretary to the Commission. [FR Doc. E9–15387 Filed 6–29–09; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE sroberts on PROD1PC70 with NOTICES6 Notice of Lodging Proposed Consent Decree In accordance with Departmental Policy, 28 CFR 50.7, notice is hereby given that a proposed Consent Decree in United States v. JLG Enterprises, et al., D. Minn., Civil No. 09–00708, was lodged with the United States District Court for the District of Minnesota on June 23, 2009. This proposed Consent Decree concerns a complaint filed by the United States against Jeffrey Gilbert, individually and d/b/a/JLG Enterprises; Gary Gilbert, individually and d/b/a JLG Enterprises; JLG Enterprises, a Minnesota general partnership; and JLG Enterprises of Hermantown, LLP, a Minnesota limited liability partnership, pursuant to sections 301(a), 309 and 404 of the Clean Water Act, 33 U.S.C. 1311(a), 1319 and 1344, to obtain injunctive relief from and impose civil penalties against the Defendants for violating the Clean Water Act by discharging pollutants without a permit into waters of the United States. The proposed Consent Decree resolves these allegations by requiring the Defendants to restore the impacted areas and/or perform mitigation and to pay a civil penalty. The Department of Justice will accept written comments relating to this VerDate Nov<24>2008 19:55 Jun 29, 2009 Jkt 217001 proposed Consent Decree for thirty (30) days from the date of publication of this Notice. Please address comments to Joshua M. Levin, U.S. Department of Justice, Environment & Natural Resources Division, Environmental Defense Section, P.O. Box 23986, Washington, DC 20026–3986, and refer to United States v. JLG Enterprises, DJ # 90–5–1–1–18212. The proposed Consent Decree may be examined at the Clerk’s Office, United States District Court for the District of Minnesota, 300 South 4th Street, Suite 202, Minneapolis, MN 55415. In addition, the proposed Consent Decree may be viewed at https://www.usdoj.gov/ enrd/Consent_Decrees.html. Maureen M. Katz, Assistant Section Chief, Environment & Natural Resources Division. [FR Doc. E9–15389 Filed 6–29–09; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Notice of Lodging of Proposed Consent Decree Under the Federal Water Pollution Control Act Notice is hereby given that on June 12, 2009, a proposed Consent Decree was filed with the United States District Court for the District of Nebraska in United States et al. v. City of West Point, et al., No. 08–00293 (D. Neb.). The proposed Consent Decree entered into by the United States, the State of Nebraska, and West Point Dairy Products, LLC resolves the United States’ claims against West Point Dairy Products, LLC under Sections 307 and 309 of the Federal Water Pollution Control Act (Clean Water Act) at its West Point, Nebraska facility. Under the terms of the Consent Decree, West Point Dairy Products, LLC shall pay a civil penalty of $75,000 each to the United States and State of Nebraska and dismiss with prejudice its cross-claims against the City of West Point, Nebraska. The Department of Justice will receive comments relating to the proposed Consent Decree for a period of thirty (30) days from the date of this publication. Comments should be addressed to the Assistant Attorney General, Environment and Natural Resources Division, and either e-mailed to pubcomment-ees.enrd@usdoj.gov or mailed to P.O. Box 7611, U.S. Department of Justice, Washington, DC 20044–7611, and should refer to United States et al. v. City of West Point, et al., DJ Ref. No. 90–5–1–1–09326. The proposed Agreement may be examined at the Office of the United States Attorney for the District of PO 00000 Frm 00077 Fmt 4703 Sfmt 4703 Nebraska, 487 Federal Building, 100 Centennial Mall North, Lincoln, NE 68508, and at the Environmental Protection Agency, Region 7, 901 N. 5th St., Kansas City, KS 66101. During the public comment period, the proposed Agreement may also be examined on the following Department of Justice Web site, https://www.usdoj.gov/enrd/ Consent_Decrees.html. A copy of the proposed Agreement may also be obtained by mail from the Consent Decree Library, P.O. Box 7611, U.S. Department of Justice, Washington, DC 20044–7611 or by faxing or e-mailing a request to Tonia Fleetwood (tonia.fleetwood@usdoj.gov), fax no. (202) 514–0097, phone confirmation number (202) 514–1547. In requesting a copy from the Consent Decree Library, please enclose a check in the amount of $5.00 (25 cents per page reproduction cost) payable to the U.S. Treasury. Maureen Katz, Assistant Section Chief, Environmental Enforcement Section, Environment and Natural Resources Division. [FR Doc. E9–15412 Filed 6–29–09; 8:45 am] BILLING CODE 4410–15–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By Notice dated April 1, 2009, and published in the Federal Register on April 9, 2009, (74 FR 16234), Lipomed, Inc., One Broadway, Cambridge, Massachusetts 02142, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedules I and II: Drug Cathinone (1235) .......................... Methcathinone (1237) ................... N-Ethylamphetamine (1475) ......... Fenethylline (1503) ....................... Methaqualone (2565) .................... Gamma Hydroxybutyric Acid (2010). Lysergic acid diethylamide (7315) 2,5-Dimethoxy-4-(n)propylthiophenethylamine. (7348) ............................................ Marihuana (7360) ......................... Tetrahydrocannabinols (7370) ...... Mescaline (7381) .......................... 3,4,5-Trimethoxyamphetamine (7390). 4-Bromo-2,5dimethoxyamphetamine (7391). E:\FR\FM\30JNN1.SGM 30JNN1 Schedule I I I I I I I I I I I I I Federal Register / Vol. 74, No. 124 / Tuesday, June 30, 2009 / Notices 31313 company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed. Schedule Drug Schedule sroberts on PROD1PC70 with NOTICES6 4-Bromo-2,5dimethoxyphenethylamine (7392). 4-Methyl-2,5dimethoxyamphetamine (7395). 2,5-Dimethoxyamphetamine (7396). 2,5-Dimethoxy-4ethylamphetamine (7399). 3,4-Methylenedioxyamphetamine (7400). 3,4-Methylenedioxy-Nethylamphetamine (7404). 3,4Methylenedioxymethamphetamine (7405). 4-Methoxyamphetamine (7411) .... Dimethyltryptamine (7435) ............ Psilocybin (7437) .......................... Psilocyn (7438) ............................. N-Benzylpiperazine (7493) ........... Acetyldihydrocodeine (9051) ........ Dihydromorphine (9145) ............... Heroin (9200) ................................ Normorphine (9313) ...................... Pholcodine (9314) ......................... Tilidine (9750) ............................... 3-Methylfentanyl (9813) ................ Amphetamine (1100) .................... Methamphetamine (1105) ............. Methylphenidate (1724) ................ Amobarbital (2125) ....................... Pentobarbital (2270) ..................... Secobarbital (2315) ...................... Phencyclidine (7471) .................... Phenylacetone (8501) ................... Cocaine (9041) ............................. Codeine (9050) ............................. Dihydrocodeine (9120) ................. Oxycodone (9143) ........................ Hydromorphone (9150) ................. Benzoylecgonine (9180) ............... Ethylmorphine (9190) ................... Hydrocodone (9193) ..................... Levorphanol (9220) ....................... Meperidine (9230) ......................... Methadone (9250) ........................ Dextropropoxyphene, bulk. (non-dosage forms) (9273) ........... Morphine (9300) ........................... Thebaine (9333) ........................... Oxymorphone (9652) .................... Alfentanil (9737) ............................ Sufentanil (9740) .......................... Fentanyl (9801) ............................. I I I I I I I Dated: June 23, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E9–15445 Filed 6–29–09; 8:45 am] I I I I I I I I I I I I II II II II II II II II II II II II II II II II II II II BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration By Notice dated February 23, 2009, and published in the Federal Register on March 2, 2009 (74 FR 9107), Sigma Aldrich Manufacturing LLC., 3500 Dekalb Street, St. Louis, Missouri 63118, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedules I and II: Drug II II II II II II II The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Lipomed, Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Lipomed, Inc. to ensure that the VerDate Nov<24>2008 19:55 Jun 29, 2009 Jkt 217001 Schedule Cathinone (1235) .......................... Methcathinone (1237) ................... Aminorex (1585) ........................... Gamma Hydroxybutyric Acid (2010). Methaqualone (2565) .................... Alpha-ethyltryptamine (7249) ........ Ibogaine (7260) ............................. Lysergic acid diethylamide (7315) Marihuana (7360) ......................... Tetrahydrocannabinols (7370) ...... Mescaline (7381) .......................... 4-Bromo-2,5dimethoxyamphetamine (7391). 4-Bromo-2,5dimethoxyphenethylamine (7392). 4-Methyl-2,5dimethoxyamphetamine (7395). 2,5-Dimethoxyamphetamine (7396). 3,4-Methylenedioxyamphetamine (7400). N-Hydroxy-3,4methylenedioxyamphetamine (7402). 3,4-Methylenedioxy-Nethylamphetamine (7404). PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 I I I I I I I I I I I I I I I I I I Drug 3,4Methylenedioxymethamphetamine (MDMA) (7405). 4-Methoxyamphetamine (7411) .... Bufotenine (7433) ......................... Diethyltryptamine (7434) ............... Dimethyltryptamine (7435) ............ Psilocybin (7437) .......................... Psilocyn (7438) ............................. 1-[1-(2Thienyl)cyclohexyl]piperdine (7470). N-Benzylpiperazine (BZP) (7493) Heroin (9200) ................................ Normorphine (9313) ...................... Etonitazene (9624) ....................... Amphetamine (1100) .................... Methamphetamine (1105) ............. Methylphenidate (1724) ................ Amobarbital (2125) ....................... Pentobarbital (2270) ..................... Secobarbital (2315) ...................... Glutethimide (2550) ...................... Nabilone (7379) ............................ Phencyclidine (7471) .................... Cocaine (9041) ............................. Codeine (9050) ............................. Diprenorphine (9058) .................... Oxycodone (9143) ........................ Hydromorphone (9150) ................. Diphenoxylate (9170) .................... Ecgonine (9180) ........................... Ethylmorphine (9190) ................... Hydrocodone (9193) ..................... Levorphanol (9220) ....................... Meperidine (9230) ......................... Methadone (9250) ........................ Morphine (9300) ........................... Thebaine (9333) ........................... Opium powdered (9639) ............... Levo-alphacetylmethadol (9648) .. Oxymorphone (9652) .................... Fentanyl (9801) ............................. I I I I I I I I I I I I II II II II II II II II II II II II II II II II II II II II II II II II II II II The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a), and determined that the registration of Sigma Aldrich Manufacturing LLC., to import the basic classes of controlled substances is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Sigma Aldrich Manufacturing LLC., to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 E:\FR\FM\30JNN1.SGM 30JNN1

Agencies

[Federal Register Volume 74, Number 124 (Tuesday, June 30, 2009)]
[Notices]
[Pages 31312-31313]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-15445]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated April 1, 2009, and published in the Federal 
Register on April 9, 2009, (74 FR 16234), Lipomed, Inc., One Broadway, 
Cambridge, Massachusetts 02142, made application by renewal to the Drug 
Enforcement Administration (DEA) to be registered as an importer of the 
basic classes of controlled substances listed in schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)............................  I
Methcathinone (1237)........................  I
N-Ethylamphetamine (1475)...................  I
Fenethylline (1503).........................  I
Methaqualone (2565).........................  I
Gamma Hydroxybutyric Acid (2010)............  I
Lysergic acid diethylamide (7315)...........  I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine
(7348)......................................  I
Marihuana (7360)............................  I
Tetrahydrocannabinols (7370)................  I
Mescaline (7381)............................  I
3,4,5-Trimethoxyamphetamine (7390)..........  I
4-Bromo-2,5-dimethoxyamphetamine (7391).....  I

[[Page 31313]]

 
4-Bromo-2,5-dimethoxyphenethylamine (7392)..  I
4-Methyl-2,5-dimethoxyamphetamine (7395)....  I
2,5-Dimethoxyamphetamine (7396).............  I
2,5-Dimethoxy-4-ethylamphetamine (7399).....  I
3,4-Methylenedioxyamphetamine (7400)........  I
3,4-Methylenedioxy-N-ethylamphetamine (7404)  I
3,4-Methylenedioxymethamphetamine (7405)....  I
4-Methoxyamphetamine (7411).................  I
Dimethyltryptamine (7435)...................  I
Psilocybin (7437)...........................  I
Psilocyn (7438).............................  I
N-Benzylpiperazine (7493)...................  I
Acetyldihydrocodeine (9051).................  I
Dihydromorphine (9145)......................  I
Heroin (9200)...............................  I
Normorphine (9313)..........................  I
Pholcodine (9314)...........................  I
Tilidine (9750).............................  I
3-Methylfentanyl (9813).....................  I
Amphetamine (1100)..........................  II
Methamphetamine (1105)......................  II
Methylphenidate (1724)......................  II
Amobarbital (2125)..........................  II
Pentobarbital (2270)........................  II
Secobarbital (2315).........................  II
Phencyclidine (7471)........................  II
Phenylacetone (8501)........................  II
Cocaine (9041)..............................  II
Codeine (9050)..............................  II
Dihydrocodeine (9120).......................  II
Oxycodone (9143)............................  II
Hydromorphone (9150)........................  II
Benzoylecgonine (9180)......................  II
Ethylmorphine (9190)........................  II
Hydrocodone (9193)..........................  II
Levorphanol (9220)..........................  II
Meperidine (9230)...........................  II
Methadone (9250)............................  II
Dextropropoxyphene, bulk....................
(non-dosage forms) (9273)...................  II
Morphine (9300).............................  II
Thebaine (9333).............................  II
Oxymorphone (9652)..........................  II
Alfentanil (9737)...........................  II
Sufentanil (9740)...........................  II
Fentanyl (9801).............................  II
------------------------------------------------------------------------

    The company plans to import analytical reference standards for 
distribution to its customers for research and analytical purposes.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of Lipomed, Inc. to import the basic classes of controlled 
substances is consistent with the public interest and with United 
States obligations under international treaties, conventions, or 
protocols in effect on May 1, 1971, at this time. DEA has investigated 
Lipomed, Inc. to ensure that the company's registration is consistent 
with the public interest. The investigation has included inspection and 
testing of the company's physical security systems, verification of the 
company's compliance with State and local laws, and a review of the 
company's background and history. Therefore, pursuant to 21 U.S.C. 
952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above 
named company is granted registration as an importer of the basic 
classes of controlled substances listed.

    Dated: June 23, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E9-15445 Filed 6-29-09; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.